Clinical Research

Includes retrospective studies looking for patterns in patient treatments and outcomes, operations and patient safety research, dose measurements using theoretical "phantoms" (like crash test dummies, but for radiation dose), treatment-related software development, clinical trials and more.

Sheets honored by the cancer center for IMRT publication
One of only five honorees.
Chen receives a UNC Health-E-NC grant
To improve survivorship services for patients with breast, colorectal, lung and prostate cancer.
Price and colleagues win a 2013 NC Cancer Hospital Endowment Fund Award
For research to reduce treatment discomfort for patients receiving radiotherapy for gynecological cancers.
News
$3.3M to study prostate cancer therapies
Comparative study will focus on minority, underserved populations.
Apisarnthanarax, Brady: Best poster awards at 2008 UNC Lineberger retreat
Chen awarded grant to study heart/prostate risk factors
A formal public award announcement will be at the June RTOG meeting
Chen paper: IMRT better than Protons/CRT
In comparing IMRT, Proton and conformal therapies, they conclude that IMRT is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence.
Chera/Rosenman/Fried paper: Pre-treatment PET and chemoradiotherapy
Paper accept in Head & Neck
Chera: Squamous Cell Carcinoma paper in JCO
Nanoparticles Promise Delivery of Abandoned Cancer Drug
A team of UNC researchers developed nanoparticle carriers to successfully deliver therapeutic doses of a cancer drug that had previously failed clinical development due to pharmacologic challenges.
Sheets Wins ASCO Merit Award
Nathan Sheets, M.D. was recently selected to receive a 2012 ASCO Conquer Cancer Foundation Merit Award.
Tepper paper: IMRT and cisplatin study published in IJROBP
Phase II Trial for Stage III and IVa Head and Neck Cancer
Wang Awarded Imaging Science Grant
Wang paper: Extended Hydrogel Microparticle Circulation Time published in PNAS
Gastrointestinal Cancer SPORE
Goal: use of combined modality therapy in the treatment of diseases of the GI tract, and assessing possible biological indicators of treatment response.
Breast Cancer SPORE
Goal: use a team approach to review cases before treatment begins, rather than after treatment decisions have been made.
Zagar wins a 2013 Junior Faculty Development Award
Chang featured in UNC Endeavors magazine